Table 4.

Tumor response according to the subtype

Subtype of PTCLALCL, ALK negative (n = 7)ALCL, ALK positive (n = 1)AITL
(n = 9)		Hepatosplenic T-cell lymphoma (n = 1)PTCL, NOS (n = 34)
CR 3 (43%) 1 (100%) 5 (56%) 0 24 (71%) 
PR 3 (43%) 0 2 (22%) 0 6 (18%) 
Stable disease 1 (14%) 0 1 (11%) 0 0 
Progressive disease 0 0 0 0 4 (12%) 
Not evaluable 0 0 1 (11%) 1 (100%) 0 
Subtype of PTCLALCL, ALK negative (n = 7)ALCL, ALK positive (n = 1)AITL
(n = 9)		Hepatosplenic T-cell lymphoma (n = 1)PTCL, NOS (n = 34)
CR 3 (43%) 1 (100%) 5 (56%) 0 24 (71%) 
PR 3 (43%) 0 2 (22%) 0 6 (18%) 
Stable disease 1 (14%) 0 1 (11%) 0 0 
Progressive disease 0 0 0 0 4 (12%) 
Not evaluable 0 0 1 (11%) 1 (100%) 0 
View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal